P/E ratio for 1-800-PetMeds (PETS)
P/E ratio as of April 2024 (TTM): -13.7
According to 1-800-PetMeds 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -13.6563. At the end of 2022 the company had a P/E ratio of 31.1.
P/E ratio history for 1-800-PetMeds from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 31.1 | 32.98% |
| 2021 | 23.4 | 12.35% |
| 2020 | 20.8 | 10.64% |
| 2019 | 18.8 | 64.22% |
| 2018 | 11.5 | -56.94% |
| 2017 | 26.6 | 24.56% |
| 2016 | 21.4 | 24.63% |
| 2015 | 17.1 | 2.58% |
| 2014 | 16.7 | -8.57% |
| 2013 | 18.3 | 36.65% |
| 2012 | 13.4 | 1.78% |
| 2011 | 13.1 | -25.49% |
| 2010 | 17.6 | 13.83% |
| 2009 | 15.5 | -17.4% |
| 2008 | 18.8 | 20.9% |
| 2007 | 15.5 | -32.6% |
| 2006 | 23.0 | -22.03% |
| 2005 | 29.5 | 20.26% |
| 2004 | 24.5 | 12.51% |
| 2003 | 21.8 | 88.7% |
| 2002 | 11.6 | -274.23% |
| 2001 | -6.64 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 CVS Health CVS | 10.1 | -173.89% | 🇺🇸 USA |
 Rite Aid
RAD | -0.0219 | -99.84% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.